Nicotine Dependence Suspended Phase 1 / 2 Trials for Atomoxetine (DB00289)

Also known as: Nicotine dependence, unspecified / Nicotine addiction

IndicationStatusPhase
DBCOND0030647 (Nicotine Dependence)Suspended1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02046551Atomoxetine's Effects On Nicotine Response And Stress Response In SmokersTreatment